Presentation The Structural Heart Disease Summit 2018 Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future! Presenter: Susheel K. Kodali, Michael J. Reardon, Mathew Williams June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes Presenter: Michael J. Mack, John D. Carroll June 21, 2018
Presentation The Structural Heart Disease Summit 2018 New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS Presenter: Michael J. Mack, Bernard Prendergast June 21, 2018
Presentation The Structural Heart Disease Summit 2018 An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research Presenter: Michael J. Mack, Nicolo Piazza June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network Presenter: Michael J. Mack June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN) Presenter: Michael J. Mack, John C Laschinger June 21, 2018
News Conference News The Structural Heart Disease Summit 2018 Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year Michael O'Riordan June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon June 21, 2018
Presentation The Structural Heart Disease Summit 2018 A Surgeons Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR Presenter: John C Laschinger, Mathew Williams, Michael J. Mack June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Case #3: A Small (Undersized) Surgical Bioprosthesis Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Case #1: A Poorly Visible Surgical Bioprosthesis Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Updates from the PARTNER Aortic Valve-in-Valve Registry Presenter: Vinayak Bapat, Ran Kornowski, Michael J. Mack June 21, 2018
Podcast TCTMD Talking Points DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis June 20, 2018
News Daily News Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk Michael O'Riordan June 20, 2018
News Daily News Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle Michael O'Riordan June 18, 2018
News Daily News Serial CTA Shines a Light on Statin Effects in Subclinical CAD Yael L. Maxwell June 15, 2018
News Daily News Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors Michael O'Riordan June 13, 2018
News Daily News Erectile Dysfunction Is an Independent Predictor of Cardiovascular Events Shelley Wood June 12, 2018